Impact of the covid-19 pandemic on tuberculosis diagnosis in the general population and the prison population in Manaus, Amazonas
DOI:
https://doi.org/10.21527/2176-7114.2025.50.15437Keywords:
Social isolation, COVID-19, Pulmonary tuberculosis, Drug resistanceAbstract
Introduction: During the pandemic, health services were restructured to meet the demand from COVID-19 cases, which led to the neglect of other diseases, including tuberculosis (TB). Objective: Assess whether there was a change in the number of TB cases identified using the rapid molecular test for tuberculosis and whether there was an increase in resistance to antituberculosis drugs after the pandemic, both in the general population and the prison population. Methodology: Individuals who underwent molecular rapid testing for tuberculosis (MRT-TB) and sensitivity tests to anti-TB drugs were evaluated at the Northern District Municipal Laboratory, during the period from January 2018 to December 2022. Results: We included 12,208 (81.7%) individuals from the general population and 2,731 (18.3%) from the prison population (PP) of the city of Manaus. The initial year of the pandemic, 2020, had the highest percentage of positive tests (20.6%, n=205) in the general population. This trend continued in the following years, being equal to 12.5% (n=347) and 12.9% (n=392), in 2021 and 2022, respectively. However, in the PP, the years with the highest rates of positive exams were 2018 and 2019, with 13.1% (n=55) and 20.5% (n=50) respectively, with a significant reduction in the percentage of positive exams in later years. Resistance to the drug Isoniazid was the most frequent resistance found in both the general population and the prison population, but without a significant increase. Conclusion: The COVID-19 pandemic negatively influenced the control of tuberculosis, increasing the number of cases of this disease in the general population, and it is necessary to improve health policies to control and reduce cases of this disease.
References
1. World Health Organization. Global Tuberculosis Report 2023 [Internet]. WHO. 2023 [citado em 17 Dez. 2023]. Disponível em: https://reliefweb.int/report/world/global-tuberculosis-report-2023?gad_source=1&gclid=CjwKCAiA1fqrBhA1EiwAMU5m_xft3WOAl2ugT7HdOGyE2cTZohyZOXHbFe7zJzVFUMAfcZ8c7RdekxoCQccQAvD_BwE.
2. Secretaria de Vigilância em Saúde e Ambiente. Boletim epidemiológico de Tuberculose 2023 [Internet]. GOV.BR. www.gov.br/saude: Ministério da Saúde; 2023 Mar [citado em 17 Dez. 2023]. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/especiais/2023/boletim-epidemiologico-de-tuberculose-numero-especial-mar.2023/view
3. Ministério da Saúde [Conselho Nacional de Saúde]. RECOMENDAÇÃO No 036/2020 [Internet]. DF, Brasília: GV-CNS. 2023 Mar [citado em 17 Dez. 2023]. Disponível em: https://conselho.saude.gov.br/recomendacoes-cns/recomendacoes-2020?start=40
4. Nascimento BC, Mesquita CR, Cardoso SRO, Silva VS da. Os impactos da pandemia da COVID-19 no diagnóstico e tratamento da tuberculose. Revista Eletrônica Acervo Saúde [Internet]. 2023 Aug 24 [citado em 17 Dez. 2023];23(8):e13033. Disponível em: https://acervomais.com.br/index.php/saude/article/view/13033
5. Hentringer IMB, Ribeiro JADM, Barreto I de JB, Silva AP de SC. Efeito da pandemia da COVID-19 sobre os casos novos de tuberculose no Brasil: uma análise temporal e espacial. O mundo da Saúde [Internet]. 2023 Mar 23 [citado em 17 Dez. 2023];47(1). Disponível em: https://revistamundodasaude.emnuvens.com.br/mundodasaude/article/view/1513
6. Melo JRR, Duarte EC, Moraes MV de, Fleck K, Arrais PSD. Automedicação e uso indiscriminado de medicamentos durante a pandemia da COVID-19. Cadernos de Saúde Pública [Internet]. 2021;37(4). Disponível em: https://www.scielosp.org/pdf/csp/2021.v37n4/e00053221/pt
7. Khoshbakht R, Bonab SM, Hajizadegan H, Nooghabi ET, Ghorbani A, Asgari MM, et al. Comparing Self-Medication and Medical Supervised Treatment before Hospitalization among Patients with COVID-19: A Retrospective Case-Control Study. Journal of Infection and Public Health. 2023 Dec 1;16:119–24. Disponível em: https://pubmed.ncbi.nlm.nih.gov/37925306/
8. Silva BPM, Almeida AS, Sérgio MGM, Gatto TC, Carasek VP, Yamamura M. Drug-Resistant Tuberculosis and COVID-19: A Scoping Review on a New Threat to Antimicrobial Resistance. Rev Bras Enferm. [Internet]. 2023 [citado em 17 Dez. 2023];76(Suppl 1):e20220803. Disponível em: https://doi.org/10.1590/0034-7167-2022-0803
9. Silva LOP, Nogueira JMR. "Indiscriminate use of antibiotics during the pandemic: increasing in post-COVID-19 bacterial resistance ". Revista Brasileira de Análises Clínicas [Internet]. 2021 [citado em 17 Dez. 2023];53(2). Disponível em: https://www.rbac.org.br/artigos/uso-indiscriminado-de-antibioticos-durante-pandemia-o-aumento-da-resistencia-bacteriana-pos-COVID-19/.
10. Mbewana Ntshanka NG, Titus AM. Msagati. Trends and Progress on Antibiotic-Resistant Mycobacterium tuberculosis and Genes in relation to Human Immunodeficiency Virus. Canadian Journal of Infectious Diseases & Medical Microbiology. 2023 Nov 30;2023:1–19. Disponível em: https://www.hindawi.com/journals/cjidmm/2023/6659212/
11. Moreira TR, Lemos AC, Colodette RM, Gomes AP, Batista RS. Prevalência de tuberculose na população privada de liberdade: revisão sistemática e metanálise. Revista Panamericana de Salud Pública [Internet]. 2019 Jan 4 [citado em 17 Dez. 2023];43(16):1–9. Disponível em: https://iris.paho.org/bitstream/handle/10665.2/49671/v43e162019.pdf?sequence=1&isAllowed=y
12. Silva CZD. Tuberculose: doença epidêmica na comunidade carcerária - uma revisão literária da saúde pública brasileira. Brazilian Journal of Health Review [Internet]. 2023 Apr 7 [citado em 17 Dez. 2023];6(4):14392–403. Disponível em: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/61306
13. Ministério da Saúde. Manual de Recomendações para Diagnóstico Laboratorial de Tuberculose e Micobactérias não Tuberculosas de Interesse em Saúde Pública no Brasil [Internet]. GOV.BR. 2022 [citado em 17 Dez. 2023]. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/tuberculose/manual-de-recomendacoes-e-para-diagnostico-laboratorial-de-tuberculose-e-micobacterias-nao-tuberculosas-de-interesse-em-saude-publica-no-brasil.pdf/view
14. Hino P, Yamamoto T, Tavares G, Bertolozzi M, Taminato M, Lucimara F, et al. Impacto da COVID-19 no controle e reorganização da atenção à tuberculose. Acta Paul Enferm [Internet]. 2021 [citado em 17 Dez. 2023];34:2115. Disponível em: https://www.scielo.br/j/ape/a/7CHK6rszL4RzWRsrYQb4mVn/
15. Dheda K, Perumal T, Moultrie H, Perumal R, Esmail A, Scott AJ, et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions. The Lancet Respiratory Medicine [Internet]. 2022 Jun [citado em 17 Dez. 2023];10(6):603–22. Disponível em: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00092-3/fulltext
16. Oliveira G, Tolentino A, Fagundes L, Santos A, Santos A, Bandeira R, et al. Impacto Da COVID-19 Na Morbimortalidade Da Tuberculose No Brasil. Brasil PsychTech & Health Journal [Internet]. 2023 [citado em 17 Dez. 2023];6(2):18–28. Disponível em: https://www.redalyc.org/journal/6880/688074836003/html/
17. Rylo I. 40 presos são achados mortos dentro de cadeias do Amazonas [Internet]. G1. 2019 [citado em 17 Dez. 2023]. Disponível em: https://g1.globo.com/am/amazonas/noticia/2019/05/27/mais-presos-sao-achados-mortos-dentro-de-cadeias-em-manaus-15-morreram-neste-domingo.ghtml
18. Marques P. Após massacre de detentos, Umanizzare deixa gestão de presídio no Amazonas [Internet]. G1. 2019 [citado em 17 Dez. 2023]. Disponível em: https://g1.globo.com/am/amazonas/noticia/2019/07/13/umanizzare-deixa-gestao-do-compaj-no-am-nova-empresa-assume-apos-governo-dispensar-licitacao-de-r-3209-milhoes.ghtml
19. Nascimento DRD, Serpa SF, Bezerra-Santos M, Carmo RFD, Brito RJVCD, Gomes OV, et al. The impact of the COVID-19 pandemic on TB diagnosis in the Brazilian prison population, 2020–2021. The International Journal of Tuberculosis and Lung Disease [Internet]. 2023 Sep 1 [citado em 17 Dez. 2023];27(9):688–93. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443780/
20. Caldas ACL, Campos AF de PE, Silva GF da, Moraes L de F da C, Morais LS, Carmo LKC do, Andrade LRF, Almeida MFBS, Araújo RCM de. Análise dos casos de tuberculose em pessoas privadas de liberdade no sistema carcerário brasileiro. Rev. Foco [Internet]. 2024 Mar. 28 [cited 2024 Jun. 6];17(3):e4767. Available from: https://ojs.focopublicacoes.com.br/foco/article/view/4767
21. Fundação Oswaldo Cruz, Escola Nacional de Saúde Pública Sergio Arouca, Centro de Referência Professor Hélio Fraga. Boletim epidemiológico da Tuberculose Drogarresistente [Internet]. FIOCRUZ/ENSP. 2022 Mar [citado em 17 Dez. 2023]. Disponível em: https://www.arca.fiocruz.br/handle/icict/51964
22. PAHO/WHO | Pan American Health Organization [Internet]. A resposta à tuberculose se recupera da pandemia, mas requer esforços acelerados para alcançar as novas metas; 7 nov 2023 [citado 6 maio 2024]. Disponível em: https://www.paho.org/pt/noticias/7-11-2023-resposta-tuberculose-se-recupera-da-pandemia-mas-requer-esforcos-acelerados-para#:~:text=A%20OMS%20informa%20que%20os,infecciosa%20do%20mundo%20em%202022.
23. Ministério da Saúde [Internet]. Tuberculose tem cura; conheça a atuação do Ministério da Saúde para eliminar a doença no Brasil; 24 mar 2023 [citado 6 maio 2024]. Disponível em: https://www.gov.br/saude/pt-br/assuntos/noticias/2023/marco/tuberculose-tem-cura-conheca-a-atuacao-do-ministerio-da-saude-para-eliminar-a-doenca-no-brasil
24. Ministério da Saúde [Internet]. Ministério da Saúde lança campanha de combate à tuberculose e reforça ações para eliminação da doença no Brasil; 24 mar 2023 [citado 6 maio 2024]. Disponível em: https://www.gov.br/saude/pt-br/assuntos/noticias/2023/marco/ministerio-da-saude-lanca-campanha-de-combate-a-tuberculose-e-reforca-acoes-para-eliminacao-da-doenca-no-brasil
25. Diniz DS, Teixeira ED, Almeida WG, Souza MS. Covid-19 e Doenças Negligenciadas ante as desigualdades no Brasil: uma questão de desenvolvimento sustentável. Saude Em Debate [Internet]. Dez 2021 [citado 6 maio 2024];45(spe2):43-55. Disponível em: https://doi.org/10.1590/0103-11042021e203
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Context and Health Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
By publishing in Revista Contexto & Saúde, authors agree to the following terms:
The works are licensed under the Creative Commons Atribuição 4.0 Internacional (CC BY 4.0) license, which allows:
Share — to copy and redistribute the material in any medium or format;
Adapt — to remix, transform, and build upon the material for any purpose, including commercial.
These permissions are irrevocable, provided that the following terms are respected:
Attribution — authors must be properly credited, with a link to the license and indication of any changes made.
No additional restrictions — no legal or technological measures may be applied that restrict the use permitted by the license.
Notes:
The license does not apply to elements in the public domain or covered by legal exceptions.
The license does not grant all rights necessary for specific uses (e.g., image rights, privacy, or moral rights).
The journal is not responsible for opinions expressed in the articles, which are the sole responsibility of the authors. The Editor, with the support of the Editorial Board, reserves the right to suggest or request modifications when necessary.
Only original scientific articles presenting research results of interest that have not been published or simultaneously submitted to another journal with the same objective will be accepted.
Mentions of trademarks or specific products are intended solely for identification purposes, without any promotional association by the authors or the journal.
License Agreement (for articles published from September 2025): Authors retain copyright over their article and grant Revista Contexto & Saúde the right of first publication.
